DOETINCHEM, NL / ACCESS Newswire / October 23, 2026 / The operator of strateslab.com, trading as Strate Labs, is outlining its published approach to product documentation following its reported return to business. The update focuses on how research buyers can connect the material described on a listing with the lot identifiers and analytical records relevant to a proposed purchase.
strateslab.com's company information describes batch and lot coding and the publication of laboratory reports on product pages. These are the supplier's stated procedures, rather than an independent certification of every listed product. The website's homepage, catalog and contact pages were accessible during the 20 October review.
Connecting a product listing to its supporting record
The supplier's published process describes sampling incoming materials and obtaining outside analysis before approval. The Strate Labs testing information provides background on that process. For an individual purchase, the relevant question is which document supports the particular lot being offered.
A product name identifies the material, but the supplied format, quantity and lot reference add information needed for a purchasing record. The report should be read with those details available. Where a listing and document use different identifiers, the current operator can be asked to explain the connection before procurement approval.
Ostarine and cardarine catalog images retrieved from strateslab.com. Product photographs illustrate listings and do not verify analytical results.
Reading the date and scope of a lab report
An analytical result relates to the sample described and the measurements performed. The report date helps place that record in time; it does not, on its own, establish which lot is presently supplied. A buyer can ask the operator to identify the offered batch and the record that applies to it.
Purity and concentration are different attributes, and a result for one should not automatically be treated as evidence of the other. Nor does a general purity statement establish sterility or package contents. The laboratory purchasing the material should determine which attributes its acceptance process requires and whether the available record addresses them.
The same distinction applies to product images. A photograph can help identify the presentation of a catalog item, but it does not independently establish the identity, quantity or composition of material in a delivered package. The written specification and relevant batch documentation remain separate parts of the assessment.
Keeping documentation available after purchase
Researchers can retain the selected specification and any supporting report with the order confirmation. When the package arrives, the receiving team can compare its identifiers with that record and ask the supplier about any difference. A report associated with an earlier purchase should not automatically be assigned to a newly supplied lot.
Requests for a missing record or clarification can be directed to Strate Labs documentation support. Including the compound name, lot identifier and current order reference helps define the document being requested.
Context for the reported return
The older stratelabs.com domain continues to display a permanent-closure notice and does not identify strateslab.com as a replacement. The reported return is the current operator's statement; legal continuity with the former business has not been independently established. Historical accounts and transaction obligations require their own clarification.
About Strate Labs at strateslab.com
strateslab.com presents research compounds and laboratory supplies under the Strate Labs name, with product information and published customer contact details. Materials are labeled for laboratory research use only and are not intended for human consumption, medical, veterinary or household use.
Published contact address: Spoorstraat 11b, 7003 DX Doetinchem, Netherlands
Media Contact Details
Strate Labs
support@strateslab.com
strateslab.com
SOURCE: Strate Labs
View the original press release on ACCESS Newswire